New York, NY (PRWEB) April 03, 2013
The Pradaxa lawyers at Bernstein Liebhard LLP note that a new study involving laboratory mice has found that potential Pradaxa side effects may include increased susceptibility to certain viral illnesses. The study, which appears in the March 2013 issue of The Journal of Clinical Investigation, suggested that Pradaxa’s action of inhibiting the clotting agent thrombin might also interfere with other beneficial processes involved in the body’s immune system. Among other things, the study found that Pradaxa was associated with an increased risk of myocarditis, a viral infection of the heart and a significant cause of sudden death.*
“We have heard from numerous individuals who have suffered serious, life-threatening episodes of internal bleeding while taking Pradaxa. This study is just more evidence that Pradaxa side effects can be extremely dangerous,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s Pradaxa lawyers are currently offering free legal evaluations to victims of alleged Pradaxa side effects.
Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2012 to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. Court records indicate that more than 358 plaintiffs have filed Pradaxa lawsuits in a multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. Among other things, the lawsuits alleged that Boehringer Ingelheim sold the blood thinner despite knowing it could cause fatal bleeding in some patients, and failed to adequately warn that there was no readily-available antidote for Pradaxa bleeding. According to court documents, the first trials in the Pradaxa litigation are scheduled to begin in September 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
According to a recent Bloomberg.com report, regulators in several countries have issued Pradaxa side effect alerts since the drug was first brought to market. Bloomberg.com also noted that the FDA received reports of 542 deaths and 3,781 side-effect incidents tied to Pradaxa in 2011, and that a recent analysis of FDA hemorrhage reports found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.**
Pradaxa lawsuits allege that one of the major issues with the blood thinner is the fact that there exists no readily available antidote for internal bleeding that can sometimes occur in patients treated with the drug. Dialysis can be used to remove Pradaxa from the blood stream. However, a study published last May in the journal, Neurology, found this treatment is risky and may not be administered in enough time to stop this potentially deadly Pradaxa side effect.***
Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information is available at Bernstein Liebhard LLP’s website, or by calling 1-877-779-1414 to speak with a Pradaxa lawyer today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com